NPR3 and irritable bowel syndrome: Linaclotide, a 14-amino-acid peptide with three disulfide bonds, interacts with guanylate cyclase-C, generating cyclic guanosine monophosphate (cGMP), and is currently in clinical use for patients with chronic constipation or irritable bowel syndrome [10].